Julie Gralow is Executive Vice President and Chief Medical Officer of the American Society of Clinical Oncology (ASCO). She is a breast medical oncologist and Professor Emeritus of Medical Oncology at the University of Washington School of Medicine, where she spent more than 25 years directing the Breast Medical Oncology program and serving as an Affiliate Professor of Global Health. Dr. Gralow is an internationally recognized leader in breast cancer clinical trials, survivorship, and global oncology.
She previously served as Executive Officer for Breast and Lung Cancer and Vice Chair of the Breast Cancer Committee for the SWOG Cancer Clinical Trials Network, and has held numerous ASCO leadership roles, including Chair of the Academic Global Oncology Task Force and Co-Chair of the Resource-Stratified Guideline Working Group.
A longstanding advocate for patient-centered and equitable cancer care, Dr. Gralow is the co-founder of Team Survivor Northwest, supporting fitness and survivorship for women with cancer, and founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN), advancing cancer education and advocacy in low- and middle-income countries. Her contributions have been recognized with the ASCO Humanitarian Award.
The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards better outcomes, advocacy, philanthropy, leadership and education. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential People in Oncology in 2025 and stay tuned for the results of special category nominations to be announced.
